Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00262002

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

Prevention of Meningococcal Disease Clinical Trial

Official title:
A Phase II, Randomized, Open Label, Controlled, Multicenter Study to Evaluate the Safety, Immunogenicity and Induction of Immunological Memory After Two or Three Doses of Novartis (Formerly Chiron) Meningococcal ACWY Conjugate Vaccine Administered to Healthy Infants at 2, 3, 4 or 2, 4, 6 Months of Age

Clinical Trial Summary

The purpose of this study is to evaluate the safety, immunogenicity and induction of immune memory after two or three doses of Novartis (Formerly Chiron) Meningococcal ACWY Conjugate Vaccine administered to healthy infants.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00262002
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 2
Start date September 2004
Completion date October 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT00262041 - Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents Phase 2
Completed NCT00262028 - Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children Phase 2